Protocol

    REN532: Treatment for Very Low, Low and Standard Risk Favorable Histology Wilms Tumor

    Diseases

    Solid Tumor : Wilms tumor

    Description

    Wilms tumor is the most common tumor of the kidney, and is seen mainly in young children. There are several stages assigned to these tumors. The stage is determined by how large the tumor is, how far it has spread, and if other tissue has become involved in the disease. The stage of the disease determines the treatment that is given to the patient.

    Participants in this research study are also enrolled in another research study known as RENBIO. The RENBIO study evaluates the tumor cells, images of the tumor and its location in the body, and tests to determine the genetic make-up of the tumor. The study provides information that can help better predict the outcome of treating the tumor. Treatments available in this research study are based on the staging and the information gathered from the RENBIO study results.


    Objectives


    Eligibility

    For the current eligibility status of this clinical study, referring physicians must contact St. Jude Children's Research Hospital at 1-866-2ST-JUDE (1-866-278-5833).


    Contact

    Rachel Brennan, MD
    St. Jude Children’s Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105 USA
    Voice: 1-888-226-4343 or 901-595-4055
    Fax: 901-595-4011

    Referring or consulting physicians only: protocolinfo@stjude.org
    For all other inquiries about St. Jude Children's Research Hospital studies: info@stjude.org


    The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.